Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...

A multi-institute collaboration of 26 researchers led by the Mayo Clinic has developed a new asthma burden score that ...

The clinical trial, led by scientists from King’s College London and sponsored by the University of Oxford, with support from drug firm AstraZeneca UK, was conducted at Oxford University Hospitals NHS ...

The APG777 + APG990 coformulation has been shown to retain stability, injectability, and convenience of individual components. In preclinical studies it has demonstrated broad inhibition of Type 1, ...

A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...

An injection of a drug already on the market, Benralizamab, promises to be the next revolution in the treatment of asthma ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Luckily, many of the worst-offending devices are what are known as “rescue inhalers”, which doctors were turning away from ...

Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Researchers at King's College London have found a new treatment for asthma attacks, which could be a 'game-changer' for the patients.